Info Sheets , Modified Release , Formulation Development

Modified-Release Formulation Strategies

Overview

CRDMO services that enable modified-release dosage forms to get to market. Fast.

Quotient Sciences capabilities for modified-release span the entire development pathway, from candidate development through to commercialization, reducing development risks and simplifying the supply chain for our customers. By taking a unique, integrated approach that is tailored to each program, we provide optimal results for our customers in the most efficient and cost-effective manner, getting new medicines to patients faster.

Modified-release formatObjectiveFormulation technology
Gastro-retention
  • Keep the formulation in the stomach for an extended period to maximize the duration of absorption or therapeutic activity
Swellable tablets (monolithic, bilayer, trilayer)
Gastro-resistant
  • Prevent release of the drug in the stomach and/or upper gastrointestinal (GI) tract
  • Overcome first-pass metabolism or gastric irritation
Enteric-coated tablets or capsules
Sustained or extended release
  • Extend the in-vivo release profile of the drug or enable once-daily dosing
Matrix tablets, coated tablets, or multiparticulates
Targeted or controlled delivery
  • Release the drug at or near the intended site of absorption or action
  • Have either immediate-release or extended-release characteristics
  • Deliver time-, pH-, or microbially-triggered release
Tablets, capsules, or multiparticulates
Biphasic release
  • Eliminate the need for repeat dosing
  • Provide rapid therapeutic effect from an immediate-release layer and extended dosing from a sustained-release layer
Bilayer tablets or multiparticulates
Pulsatile release
  • Release the drug as a pulse after a pre-determined lag time, designed according to the body’s circadian rhythm
  • Provide a release mechanism beneficial for drugs where time-dependent dosing is required or those that undergo first-pass metabolism
Bilayer tablets or multiparticulates
Download
Quotient Sciences Logo
Translational Pharmaceutics, Formulation Development

On-Demand: Leveraging Real-Time Clinical Data to Deliver Certainty in Solubility Enhancement and Modified Release Development

12 December 2024 Watch Now
Learn more about Quotient Sciences' services

See how we can help you with your next drug program.

Drug Substance Synthesis & Manufacturing
Capabilities including route scouting, PR&D, small-scale GMP manufacture, DOE/QbD, and 14C labelling.
Explore More
Translational Pharmaceutics® Integrated Drug Development
Our unique approach to drug development, integrating clinical activities with real-time cGMP drug product manufacturing.
Discover More
Early Clinical Development
Integrated first-in-human and clinical pharmacology programs that help you make critical decisions earlier.
Discover More
Drug Product Development & Manufacturing
Experienced formulation development, clinical manufacturing, and sustained commercial production of your product.
Explore Service
Let's Talk
Humanity can't wait, so neither can we. Discuss your drug program today.
Contact Us Ask the Experts